282 related articles for article (PubMed ID: 34873461)
1. m
Xu L; Li Q; Wang Y; Wang L; Guo Y; Yang R; Zhao N; Ge N; Wang Y; Guo C
Am J Cancer Res; 2021; 11(11):5282-5298. PubMed ID: 34873461
[TBL] [Abstract][Full Text] [Related]
2. METTL3 facilitates tumor progression via an m
Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
[TBL] [Abstract][Full Text] [Related]
3. METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m
Liu L; Wu Y; Li Q; Liang J; He Q; Zhao L; Chen J; Cheng M; Huang Z; Ren H; Chen J; Peng L; Gao F; Chen D; Wang A
Mol Ther; 2020 Oct; 28(10):2177-2190. PubMed ID: 32621798
[TBL] [Abstract][Full Text] [Related]
4. METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3.
Yi J; Peng F; Zhao J; Gong X
Sci Rep; 2023 Oct; 13(1):17292. PubMed ID: 37828232
[TBL] [Abstract][Full Text] [Related]
5. METTL3 suppresses anlotinib sensitivity by regulating m
Chen J; Li S; Huang Z; Cao C; Wang A; He Q
Cancer Cell Int; 2022 Sep; 22(1):295. PubMed ID: 36167542
[TBL] [Abstract][Full Text] [Related]
6. METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m
Zhao W; Cui Y; Liu L; Ma X; Qi X; Wang Y; Liu Z; Ma S; Liu J; Wu J
Mol Ther Nucleic Acids; 2020 Jun; 20():1-12. PubMed ID: 32145676
[TBL] [Abstract][Full Text] [Related]
7. METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m
Xu Y; Lv D; Yan C; Su H; Zhang X; Shi Y; Ying K
Cancer Cell Int; 2022 Jan; 22(1):11. PubMed ID: 34996469
[TBL] [Abstract][Full Text] [Related]
8. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.
Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S
Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946
[TBL] [Abstract][Full Text] [Related]
9. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
10. N
Xu K; Dai X; Wu J; Wen K
J Cancer Res Clin Oncol; 2022 Dec; 148(12):3375-3384. PubMed ID: 35763110
[TBL] [Abstract][Full Text] [Related]
11. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
[TBL] [Abstract][Full Text] [Related]
12. METTL3-Mediated m
Huang N; Gao Y; Zhang M; Guo L; Qin L; Liao S; Wang H
Front Cell Dev Biol; 2022; 10():894810. PubMed ID: 35774226
[TBL] [Abstract][Full Text] [Related]
13. METTL3-Mediated Maturation of miR-99a-5p Promotes Cell Migration and Invasion in Oral Squamous Cell Carcinoma by Targeting ZBTB7A.
Huang Y; Guan Y; Zhang X
Mol Biotechnol; 2023 Jul; ():. PubMed ID: 37498409
[TBL] [Abstract][Full Text] [Related]
14. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
15. LAMA3 Promotes Tumorigenesis of Oral Squamous Cell Carcinoma by METTL3-Mediated N6-Methyladenosine Modification.
Ning B; Mei Y
Crit Rev Immunol; 2024; 44(2):49-59. PubMed ID: 38305336
[TBL] [Abstract][Full Text] [Related]
16. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.
Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Lv X; Zou C
J Immunol Res; 2021; 2021():6149558. PubMed ID: 34476262
[TBL] [Abstract][Full Text] [Related]
17. Methyltransferase-like 3-induced N6-methyladenosine upregulation promotes oral squamous cell carcinoma by through p38.
Xu T; Zhang W; Chai L; Liu C; Zhang S; Xu T
Oral Dis; 2023 Mar; 29(2):639-648. PubMed ID: 34479400
[TBL] [Abstract][Full Text] [Related]
18. METTL3 Contributes to Osteosarcoma Progression by Increasing DANCR mRNA Stability
Zhou X; Yang Y; Li Y; Liang G; Kang D; Zhou B; Li Q
Front Cell Dev Biol; 2021; 9():784719. PubMed ID: 35096816
[No Abstract] [Full Text] [Related]
19. MiR-375/SLC7A11 axis regulates oral squamous cell carcinoma proliferation and invasion.
Wu Y; Sun X; Song B; Qiu X; Zhao J
Cancer Med; 2017 Jul; 6(7):1686-1697. PubMed ID: 28627030
[TBL] [Abstract][Full Text] [Related]
20. METTL3 facilitates prostate cancer progression via inducing HOXC6 m6A modification and stabilizing its expression through IGF2BP2-dependent mechanisms.
He P; Liu X; Yu G; Wang Y; Wang S; Liu J; An Y
Mol Cell Biochem; 2024 May; ():. PubMed ID: 38822192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
